section name header

Table 70-1

Staging of Breast Cancer

Primary Tumor (T)
T0No evidence of primary tumor
TISCarcinoma in situ
T1Tumor 2 cm
T1aTumor >0.1 cm but 0.5 cm
T1bTumor >0.5 but 1 cm
T1cTumor >1 cm but 2 cm
T2Tumor >2 cm but 5 cm
T3Tumor >5 cm
T4Extension to chest wall, inflammation, satellite lesions, ulcerations
Regional Lymph Nodes (N)
PN0(i-)No regional lymph node metastasis histologically, negative IHC
PN0(i+)No regional lymph node metastasis histologically, positive IHC, no IHC cluster >0.2 mm
PN0(mol-)No regional lymph node metastasis histologically, negative molecular findings (RT-PCR)
PN0(mol+)No regional lymph node metastasis histologically, positive molecular findings (RT-PCR)
PN1Metastasis in one to three axillary lymph nodes, or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent
PN1miMicrometastasis (>0.2 mm, none >2 mm)
PN1aMetastasis in one to three axillary lymph nodes
PN1bMetastasis in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent a
PN1cMetastasis in one to three axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent.a (If associated with greater than three positive axillary lymph nodes, the internal mammary nodes are classified as pN3b to reflect increased tumor burden.)
pN2Metastasis in four to nine axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis
pN3Metastasis in 10 or more axillary lymph nodes, or in infraclavicular lymph nodes, or in clinically apparenta ipsilateral internal mammary lymph nodes in the presence of one or more positive axillary lymph nodes; or in more than three axillary lymph nodes with clinically negative microscopic metastasis in internal mammary lymph nodes; or in ipsilateral subcarinal lymph nodes
Distant Metastasis (M)
M0No distant metastasis
M1Distant metastasis (includes spread to ipsilateral supraclavicular nodes)
Stage Grouping
Stage 0TISN0M0
Stage IT1N0M0
Stage IIAT0N1M0
T1N1M0
T2N0M0
Stage IIBT2N1M0
T3N0M0
Stage IIIAT0N2M0
T1N2M0
T2N2M0
T3N1, N2M0
Stage IIIBT4Any NM0
Any TN3M0
Stage IIICAny TN3M0
Stage IVAny TAny NM1

aClinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination.

Abbreviations: IHC, immunohistochemistry; RT-PCR, reverse transcriptase/polymerase chain reaction.

Source: Used with permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, 7th ed. New York, Springer, 2010; www.springeronline.com.